Initial Statement of Beneficial Ownership of Securities

This filing details the beneficial ownership of securities by Tasso Partners, LLC, a 10% owner of PAVmed Inc. The filing reports the ownership of 912,996 shares of Common Stock. Additionally, it discloses warrants to purchase up to 5,365 shares of Series D Preferred Stock, with an exercise price of $1,000 per share. Each share of Series D Preferred Stock is convertible into shares of Common Stock at a conversion price of $6.50 per share. The warrants have an exercise date of February 3, 2026, and an expiration date of February 3, 2031. The reporting owner, Tasso Partners, LLC, holds these securities directly.